Multiple myeloma is a blood cancer that starts in plasma cells, a type of white blood cell in the bone marrow that makes infection-fighting antibodies. Cancerous plasma cells build up in the bone marrow, crowd out healthy blood cells, and produce abnormal proteins called monoclonal (M) proteins that can damage organs and bones. [1, 2, 3]
Symptoms and How It Affects the Body
Early stages often cause no symptoms. As the disease progresses, doctors often look for CRAB signs and complications: [1, 2, 3]
- Calcium elevation (hypercalcemia): Bone breakdown releases calcium into the blood, causing thirst, frequent urination, nausea, constipation, or confusion. [1, 2, 3]
- Renal (kidney) damage: Abnormal M proteins, high calcium, or infections can impair kidney function.[1, 2]
- Anemia: Crowded bone marrow makes fewer red blood cells, leading to fatigue, weakness, shortness of breath, and dizziness. [1, 2, 3]
- Bone disease: Myeloma cells trigger bone breakdown, causing bone pain (often in the back, ribs, or hips), weakened spots (lytic lesions), and easier fractures. [1, 2]
- Immune and blood cell changes: Lower white blood cells raise infection risk, and lower platelets can cause easier bruising or bleeding. [1, 2, 3]
Causes and Risk Factors
The exact cause is not known. It develops from genetic changes in plasma cells and often follows precursor conditions such as monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma. Risk factors include: [1, 2, 3, 4, 5]
- Age and sex: Risk rises with older age (most common in adults over 60) and is slightly higher in men.[1, 2, 3]
- Race and family history: Incidence is higher in people of African descent and in those with a close relative who has multiple myeloma or a related plasma cell disorder. [1, 2, 3]
- Other factors: Being overweight or obese and exposure to radiation can increase risk. [1]
Progression and Prognosis
Multiple myeloma typically progresses along a spectrum—from MGUS to smoldering multiple myeloma to active multiple myeloma (and rarely, plasma cell leukemia). Doctors stage active myeloma using blood tests, urine tests, bone marrow biopsies, imaging, and genetic (cytogenetic) findings to guide treatment. [1, 2, 3]
While multiple myeloma is generally considered incurable, it is treatable with options such as targeted therapy, immunotherapy (including CAR T-cell therapy), chemotherapy, steroids, radiation, and stem cell transplants. Advances in treatment have helped people live longer, with a five-year relative survival rate reported around 64% in the U.S. (2016–2022). [1, 2, 3]
For more detailed guidance, see the Mayo Clinic overview. [1]
Are you looking into this for yourself or someone else? Sharing whether there are specific symptoms, test results, or treatment questions can help me tailor information to what you need.
From: Google Gemini AI